Domača stranDHR • NYSE
add
Danaher Corporation
190,05 $
Po zaprtju:(0,95 %)+1,80
191,85 $
Konec trgovanja: 12. sep., 19:02:27 GMT -4 · USD · NYSE · Izjava
Prejšnji trg. dan.
195,16 $
Dnevni razpon
188,86 $ - 195,00 $
Letni razpon
171,00 $ - 279,90 $
Tržna kapitalizacija
136,09 mrd. USD
Povprečni obseg
3,42 mio.
Razm. P/E
40,37
Dividendna donosnost
0,67 %
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 5,94 mrd. | 3,36 % |
Stroški poslovanja | 2,33 mrd. | 3,05 % |
Čisti dohodek | 555,00 mio. | −38,81 % |
Čista dobičkovnost prihodkov | 9,35 | −40,79 % |
Earnings per share | 1,80 | 4,65 % |
EBITDA | 1,80 mrd. | 3,26 % |
Efektivna davčna stopnja | 15,27 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 2,96 mrd. | 24,56 % |
Skupna sredstva | 81,62 mrd. | 3,90 % |
Skupne obveznosti | 29,28 mrd. | 2,18 % |
Celoten lastniški kapital | 52,34 mrd. | — |
Shares outstanding | 716,05 mio. | — |
Razmerje P/B | 2,67 | — |
Donosnost sredstev | 3,71 % | — |
Donosnost kapitala | 4,28 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 555,00 mio. | −38,81 % |
Denar iz dejavnosti | 1,34 mrd. | −5,58 % |
Denar iz naložb | −258,00 mio. | 28,33 % |
Denar iz financiranja | −247,00 mio. | 95,68 % |
Neto sprememba denarnih sredstev | 964,00 mio. | 120,70 % |
Prost denarni tok | 791,88 mio. | −30,74 % |
Vizitka
Danaher Corporation, headquartered in Washington, D.C., develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates 3 divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.
The company was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. Wikipedia
Generalni direktor
Datum ustanovitve
1969
Spletno mesto
Zaposleni
62.000
